| J9271 | Injection, pembrolizumab, 1 mg | 20,600 | $40 | $885.8K |
| J9144 | Injection, daratumumab, 10 mg and hyaluronidase‑fihj | 5,760 | $40 | $218.9K |
| J1568 | Injection, immune globulin, (octagam), intravenous, non-lyophilized (e.g., liquid), 500 mg | 3,080 | $30 | $101.8K |
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 790 | $90 | $70.6K |
| 99215 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a high level of medical decision making, and/or the… | 320 | $130 | $43.4K |
| 96413 | Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These… | 420 | $100 | $42.8K |
| J0881 | Injection, darbepoetin alfa, 1 microgram (non-esrd use) | 17,160 | $1 | $34.3K |
| J1439 | Injection, ferric carboxymaltose, 1 mg | 31,500 | $1 | $31.5K |
| 99213 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the… | 460 | $60 | $28.3K |
| J2506 | Injection, pegfilgrastim, excludes biosimilar, 0.5 mg | 240 | $90 | $20.4K |